Consolidated Consolidated Statements Of Equity (Deficit) - USD ($) $ in Thousands |
Total |
Bridge Notes |
Promissory Notes |
Retroactive application of the recapitalization |
Previously Reported |
Adoption of accounting standards |
Adjusted balance |
Common Stock warrants |
Common Stock warrants
Merger
|
Preferred Stock |
Common Stock |
Common Stock
Bridge Notes
|
Common Stock
Promissory Notes
|
Common Stock
Retroactive application of the recapitalization
|
Common Stock
Previously Reported
|
Common Stock
Adjusted balance
|
Common Stock
Common Stock warrants
|
Common Stock
Common Stock warrants
Merger
|
Common Stock
Common Class A
|
Common Stock
Common Class A
Retroactive application of the recapitalization
|
Common Stock
Common Class A
Previously Reported
|
Common Stock
Common Class A
Adjusted balance
|
Common Stock
Common Class B
|
Common Stock
Common Class B
Retroactive application of the recapitalization
|
Common Stock
Common Class B
Previously Reported
|
Common Stock
Common Class B
Adjusted balance
|
Common Stock
Preferred Stock
|
Additional Paid-in Capital |
Additional Paid-in Capital
Bridge Notes
|
Additional Paid-in Capital
Promissory Notes
|
Additional Paid-in Capital
Retroactive application of the recapitalization
|
Additional Paid-in Capital
Previously Reported
|
Additional Paid-in Capital
Adjusted balance
|
Additional Paid-in Capital
Common Stock warrants
|
Additional Paid-in Capital
Common Stock warrants
Merger
|
Additional Paid-in Capital
Preferred Stock
|
Treasury Stock |
Treasury Stock
Retroactive application of the recapitalization
|
Treasury Stock
Previously Reported
|
Treasury Stock
Adjusted balance
|
Accumulated Deficit |
Accumulated Deficit
Retroactive application of the recapitalization
|
Accumulated Deficit
Previously Reported
|
Accumulated Deficit
Adoption of accounting standards
|
Accumulated Deficit
Adjusted balance
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beginning balance, Carrying amount at Dec. 31, 2019 | $ 0 | $ (171,321) | $ 171,321 | $ 0 | |||||||||||||||||||||||||||||||||||||||||
Beginning balance, Shares outstanding (in shares) at Dec. 31, 2019 | 0 | (76,971,000) | 76,971,000 | 0 | |||||||||||||||||||||||||||||||||||||||||
Ending balance, Carrying amount at Dec. 31, 2020 | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||
Ending balance, Shares outstanding (in shares) at Dec. 31, 2020 | 0 | ||||||||||||||||||||||||||||||||||||||||||||
Balance at beginning of period at Dec. 31, 2019 | $ (18,295) | $ 171,321 | $ (189,616) | $ (650) | $ (18,945) | $ 3 | $ 3 | $ 0 | $ 3 | $ 0 | $ (1) | $ 1 | $ 0 | $ 0 | $ (1) | $ 1 | $ 0 | $ 185,501 | $ 158,820 | $ 26,681 | $ 185,501 | $ 0 | $ 12,500 | $ (12,500) | $ 0 | $ (203,799) | $ 0 | $ (203,799) | $ (650) | $ (204,449) | |||||||||||||||
Balance at beginning of period (in shares) at Dec. 31, 2019 | 31,074,000 | 31,074,000 | 0 | 31,074,000 | 0 | (72,319,000) | 72,319,000 | 0 | 0 | (83,987,000) | 83,987,000 | 0 | 0 | (11,500,000) | 11,500,000 | 0 | |||||||||||||||||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation | 2,390 | 2,390 | |||||||||||||||||||||||||||||||||||||||||||
Issuance of subsidiary preferred stock (Note 16) | $ 3,247 | $ 3,247 | |||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock upon exercise of stock options | 30 | 30 | |||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock upon exercise of stock options (in shares) | 188,000 | ||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock upon vesting of restricted stock awards (in shares) | 2,376,000 | ||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock in connection with acquisition (in shares) | 55,000 | ||||||||||||||||||||||||||||||||||||||||||||
Stock issued during period (in shares) | 999,000 | ||||||||||||||||||||||||||||||||||||||||||||
Net loss | (19,535) | (19,535) | |||||||||||||||||||||||||||||||||||||||||||
Balance at end of period at Dec. 31, 2020 | $ (32,813) | $ 3 | $ 0 | $ 0 | 191,168 | $ 0 | (223,984) | ||||||||||||||||||||||||||||||||||||||
Balance at end of period (in shares) at Dec. 31, 2020 | 34,692,000 | 34,692,000 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||
Ending balance, Carrying amount at Dec. 31, 2021 | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||
Ending balance, Shares outstanding (in shares) at Dec. 31, 2021 | 0 | ||||||||||||||||||||||||||||||||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation | $ 42,582 | 42,582 | |||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock due to Bridge Notes | 106,353 | $ 2 | 106,351 | ||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock due to Bridge Notes (in shares) | 20,343,000 | ||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock upon exercise of stock options | $ 130 | 130 | |||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock upon exercise of stock options (in shares) | 1,045,000 | 1,044,000 | |||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock upon vesting of restricted stock awards (in shares) | 546,000 | ||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock upon vesting of restricted stock units (in shares) | 111,000 | ||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock on conversion (in shares) | 7,736,000 | 1,000 | 3,251,000 | 11,187,000 | |||||||||||||||||||||||||||||||||||||||||
Issuance of common stock on conversion | $ 77,097 | $ 2,289 | $ 38,329 | $ 1 | $ 1 | $ 77,096 | $ 2,289 | $ 38,328 | |||||||||||||||||||||||||||||||||||||
Issuance of sponsor earn-out shares | $ (17,659) | (17,659) | |||||||||||||||||||||||||||||||||||||||||||
Reverse recapitalization, net (in shares) | 34,584,000 | ||||||||||||||||||||||||||||||||||||||||||||
Reverse recapitalization, net (Note 4) | 200,917 | $ 4 | 202,195 | (1,282) | |||||||||||||||||||||||||||||||||||||||||
Conversion of bridge notes and accrued interest into common stock | $ 8,038 | $ 8,038 | |||||||||||||||||||||||||||||||||||||||||||
Net loss | (245,643) | (245,643) | |||||||||||||||||||||||||||||||||||||||||||
Balance at end of period at Dec. 31, 2021 | $ 179,620 | $ 11 | $ 0 | $ 0 | $ 650,518 | $ 0 | $ (470,909) | ||||||||||||||||||||||||||||||||||||||
Balance at end of period (in shares) at Dec. 31, 2021 | 114,452,000 | 114,452,000 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||
Balance at beginning of period (in shares) at Sep. 08, 2021 | 31,625,000 | ||||||||||||||||||||||||||||||||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||||||||||||||||||||||||||||
Reverse recapitalization, net (in shares) | 34,584,000 |